Stockscreener 앱 받기
7.56
1.82%
-0.14
Leonabio Inc 주식(LONA)의 최신 뉴스
LONA Maintained by Mizuho -- Price Target Lowered to $15.00 - GuruFocus
Mizuho lowers LeonaBio stock price target on higher OpEx By Investing.com - Investing.com Nigeria
Mizuho lowers LeonaBio stock price target on higher OpEx - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
LeonaBio Reports Narrower Quarter Loss as Trial Progresses - sekbernews.id
LeonaBio (LONA) Market Close: Closes 3.19% Higher at $7.96 at the Close; Level Check: the Price Remains Bounded by the Supplied Support and Resistance under the Current SnapshotLow Volatility Picks - Vinanet
LeonaBio price target lowered to $17 from $18 at Citizens - TipRanks
LeonaBio Inc. (LONA) Climbs 2.84% to $8.19 as Biotech Buyers Target $8.60 ResistanceWedge Breakout - Vinanet
LeonaBio, Inc. (NASDAQ: LONA) Share Price, LONA Stock News, LONA Share Price & Updates - Kalkine
LONA Maintained by Citizens -- Price Target Lowered to $17.00 - GuruFocus
LeonaBio beats Q2 loss forecast as Phase 3 ELAINE-3 trial advances - Yahoo Finance
LeonaBio beats second quarter loss estimates By Investing.com - Investing.com Nigeria
LeonaBio beats second quarter loss estimates - Investing.com
LeonaBio Inc (LONA) Q2 Results Highlight Challenges for Valuatio - GuruFocus
Citizens lowers LeonaBio stock price target to $17 on valuation By Investing.com - Investing.com Canada
LeonaBio Q2 Results: EPS beats estimate, losses narrow 55% YoY - scanx.trade
LeonaBio Narrows Q2 Loss - marketscreener.com
LeonaBio Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
LeonaBio (LONA) loss widens as cash burn rises and going concern risk emerges - Stock Titan
LeonaBio Q2 net loss widens on higher R&D spending - TradingView
LeonaBio Posts $19.0 Million Q2 Loss as ELAINE-3 Enrollment Advances - Quiver Quantitative
LeonaBio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
LeonaBio’s lasofoxifene to be featured at breast cancer summit By Investing.com - Investing.com Nigeria
LeonaBio’s lasofoxifene to be featured at breast cancer summit - Investing.com
LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology’s 4th Summit on Breast Cancer - The Manila Times
LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), - GlobeNewswire
LeonaBio Ord Shs (LONA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
LONA Q1 2026 Earnings: Narrowed Loss Beats Estimates, Shares RisePost-Earnings Reaction - vinanet.vn
LONA Q1 2026 Earnings: Narrower-Than-Expected Loss Points to Cost DisciplineEPS Growth Report - vinanet.vn
LONA: LeonaBio, Inc.12 Month EPS - Zacks Investment Research
LeonaBio Inc. (LONA) Slips 2.74% to $7.45 as Biotech Stock Nears Key SupportDividend ETF - vinanet.vn
LeonaBio Inc expected to post a loss of $1.26 a shareEarnings Preview - TradingView
LeonaBio Inc. (LONA) Q1 2026 Earnings: Narrower-than-Expected Loss Driven by Expense ManagementRevenue Estimate Trend - vinanet.vn
LeonaBio Inc. (LONA) Advances 2.08%: Biotech Stock Tests Mid-Range Resistance After Oversold BounceBreakaway Gap - dars.gov.et
LONA|LeonaBio Ord Shs|Price:7.275|Chg%:-0.115 - TradingKey
LeonaBio Ord Shs (LONA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LeonaBio, Inc. Revenue Breakdown – NASDAQ:LONA - TradingView
LeonaBio Ord Shs (LONA) Institutional Confidence - TradingKey
LONA Q1 2026 Earnings: EPS Surprises to the Upside as Biotech Advances PipelineBook Value Growth - vinanet.vn
LONA Q1 2026 Earnings: Narrowed Loss Exceeds Expectations, Stock Rises 5.7%Consensus Miss Rate - vinanet.vn
LONA Q1 2026 Earnings: EPS Beat Drives 4.85% Stock Surge Despite Zero RevenueNon-GAAP Earnings - Vinanet
LeonaBio Inc. (LONA) Drops 7.55% as Selling Pressure Intensifies, Testing Key SupportMomentum Stock Picks - dars.gov.et
Mizuho Securities Remains a Buy on LeonaBio (LONA) - The Globe and Mail
LONA Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Surprise Despite Revenue AbsenceNext Quarter Guidance - vinanet.vn
LeonaBio (LONA) Tumbles 8.4% as Stock Tests Key Support Levels Near $7.42Momentum Breakout Ideas - Vinanet
LONA Q1 2026 Earnings: Beats EPS Estimates Amidst Pre-Revenue StageNet Profit Margin - dars.gov.et
LeonaBio Inc. (LONA) Gains 2.24% as Stock Approaches Key Resistance at $10.08Stop Loss Guidance - dars.gov.et
LONA Q1 2026 Earnings: Narrower-than-expected loss lifts sharesManagement Tone Analysis - dars.gov.et
Form 4 LeonaBio Inc For: 10 July By Investing.com - Investing.com Nigeria
LeonaBio (LONA) awards 28,000 stock options tied to Perceptive Advisors board role - Stock Titan
Form 4 LeonaBio Inc For: 9 July By Investing.com - Investing.com Nigeria
0.86%
0.31%
자본화:
|
볼륨(24시간):